Merck & Co to Help Cure Hepatitis in 4 Weeks with Gilead’s Sovaldi

November 10, 2014 6:36 PM

1 0

The most recent attempt by Merck & Co to help in shortening the Hepatitis C treatment to just four weeks by adding Gilead Sciences Inc’s high selling Sovaldi to their oral two-drug combination. According to the recent data from a mid-stage study, this attempt will help in decreasing the high rate of relapses, and help in reaching the desired efficiency.

There are several companies, which are also trying to find out ways to cure people from Hepatitis, and how to keep down the number of weeks of treatment for patients. This process is aimed at keeping the cure rates above 90 percent.

Also read: FCC Vote Means Internet Providers Need Permission To Share Your Data

Read more

To category page